Aktienbewertung
Konkurrenz
| Ticker | Preis | Prognose 1J | Prognose 2J | Börsenwert | Div Yld | Wachstumsrate |
|---|---|---|---|---|---|---|
|
NYSE:MRK
Merck
|
127.51 | -7,42% | 6,15% | 322.986,42 | 2,42% | -19,03% |
|
LSE:AZN
AstraZeneca PLC
|
120.50 | 19,51% | 42,34% | 186.803,32 | 2,05% | 15,98% |
|
SWX:NOVN
Novartis
|
87.97 | 14,79% | 28,99% | 179.494,55 | 3,75% | 4,67% |
|
NYSE:ABT
Abbott Laboratories
|
105.90 | 0,68% | 13,2% | 184.227,29 | 2,08% | 9,04% |
|
NYSE:PFE
Pfizer
|
27.81 | 11,74% | 42,95% | 157.475,27 | 6,04% | -9,31% |
|
ENXTPA:SAN
Sanofi
|
91.30 | 16,54% | 35,07% | 114.001,35 | 4,12% | 8,19% |
|
NSEI:SUNPHARMA
Sun Pharmaceutical Industries
|
1511.15 | -17,18% | -5,3% | 3.625.755,04 | 0,83% | 24,54% |
|
NSEI:CIPLA
Cipla
|
1424.75 | 9,62% | 22,24% | 1.130.313,89 | 0,6% | 14,64% |
|
BSE:500124
Dr. Reddy's Laboratories
|
6349.95 | 26,71% | 28,87% | 1.033.287,1 | 0,63% | 35,6% |
|
NSEI:ZYDUSLIFE
Zydus Lifesciences
|
997.40 | -32,53% | -27,56% | 959.494,42 | 0,6% | 6,43% |
|
BSE:500420
Torrent Pharmaceuticals
|
2732.60 | 55,07% | 93,38% | 893.631,34 | 1,1% | 5,98% |
|
BSE:500257
Lupin
|
1655.25 | 16,71% | 41,35% | 749.914,01 | 0,24% | -21,08% |
|
NSEI:ALKEM
Alkem Laboratories
|
4904.00 | -9,14% | 8,35% | 577.863,62 | 0,51% | 11,01% |
|
BSE:500488
Abbott India
|
26144.45 | 6,19% | 22,42% | 561.316,25 | 1,24% | 18,8% |
|
NSEI:GLENMARK
Glenmark Pharmaceuticals
|
1053.30 | -31,22% | -16,28% | 298.329,32 | 0,24% | -4,05% |
|
BSE:500302
Piramal Enterprises
|
962.05 | 57,68% | 120,58% | 207.791,46 | 3,22% | -1,43% |
|
NSEI:APLLTD
Alembic Pharmaceuticals
|
1024.30 | -29,41% | -9,28% | 201.339,61 | 0,78% | -4,49% |
|
BSE:500674
Sanofi India
|
8616.80 | 18,19% | 36,19% | 191.709,2 | 1,94% | 9,15% |
|
BSE:506820
AstraZeneca Pharma India
|
5424.45 | 0% | 0% | 133.531,25 | 0,29% | 31,68% |
|
BSE:500126
Procter & Gamble Health
|
4749.20 | 0% | 0% | 79.845,52 | 2% | 18,79% |
